Organon (OGN) Long-Term Deferred Tax (2020 - 2026)
Organon (OGN) posted quarterly Long-Term Deferred Tax of $1.5 billion for Q2 2026, down 3.37% year-over-year from $1.6 billion in Q2 2025, and down 0.78% on a QoQ basis from $1.5 billion in Q1 2026.
Organon (OGN) Long-Term Deferred Tax (2020 - 2026) Analysis & Trends
Organon has reported Long-Term Deferred Tax for 7 years, with the latest figure at $1.5 billion in Q2 2026.
- Long-Term Deferred Tax for Q2 2026 came in at $1.5 billion, down 3.37% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.5 billion (down 3.37% YoY), and the FY2025 annual result was $1.5 billion, up 3.22% from the prior year.
- Long-Term Deferred Tax retreated to $1.5 billion in Q2 2026, from $1.5 billion in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $1.6 billion in Q2 2025 and troughed at $640.0 million in Q1 2022.
- A 5-year average of $1.1 billion and a median of $1.2 billion in 2023 frame the typical range for Long-Term Deferred Tax.
- The widest annual swing landed in 2022, when Long-Term Deferred Tax slipped 11.55%; it then jumped 103.13% in 2024.
- A 5-year view of Long-Term Deferred Tax shows it stood at $754.0 million in 2022, then soared by 63.26% to $1.2 billion in 2023, then gained by 21.12% to $1.5 billion in 2024, then grew by 3.22% to $1.5 billion in 2025, then declined by 1.17% to $1.5 billion in 2026.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $1.5 billion in Q2 2026, $1.5 billion in Q1 2026, and $1.5 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.52 Bn |
| Mar 31, 2026 | 1.53 Bn |
| Dec 31, 2025 | 1.54 Bn |
| Sep 30, 2025 | 1.54 Bn |
| Jun 30, 2025 | 1.57 Bn |
| Mar 31, 2025 | 1.49 Bn |
| Dec 31, 2024 | 1.49 Bn |
| Sep 30, 2024 | 1.43 Bn |
| Jun 30, 2024 | 1.20 Bn |
| Mar 31, 2024 | 1.19 Bn |
| Dec 31, 2023 | 761.00 Mn |
| Sep 30, 2023 | 702.00 Mn |
| Jun 30, 2023 | 716.00 Mn |
| Mar 31, 2023 | 704.00 Mn |
| Dec 31, 2022 | 754.00 Mn |
| Sep 30, 2022 | 666.00 Mn |
| Jun 30, 2022 | 647.00 Mn |
| Mar 31, 2022 | 640.00 Mn |
| Dec 31, 2021 | 694.00 Mn |
| Sep 30, 2021 | 753.00 Mn |